Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
0.107
+0.004 (4.11%)
At close: Mar 9, 2026, 4:00 PM EDT
0.105
-0.002 (-1.88%)
After-hours: Mar 9, 2026, 6:15 PM EDT
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $5.93 million as of March 9, 2026. Its market cap has decreased by -90.71% in one year.
Market Cap
5.93M
Enterprise Value
-2.60M
1-Year Change
-90.71%
Ranking
Category
Stock Price
$0.11
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.58M to $5.93M, a decrease of -99.31%. That is a compound annual growth rate of -51.71%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Processa Pharmaceuticals | 6.41M |
| Aptevo Therapeutics | 6.39M |
| Can-Fite BioPharma | 6.38M |
| Aprea Therapeutics | 6.30M |
| Purple Biotech | 6.02M |
| Aspire Biopharma Holdings | 5.83M |
| Psyence Biomedical | 5.76M |
| Lunai Bioworks | 5.62M |